BSE Live
Apr 20, 16:01Prev. Close
245.35
Open Price
246.60
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Profit & Loss account of Kerala Ayurveda (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 72.69 | 73.14 | 63.30 | 55.80 | 43.20 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 72.69 | 73.14 | 63.30 | 55.80 | 43.20 | |
| Total Operating Revenues | 72.69 | 73.14 | 63.30 | 55.80 | 43.20 | |
| Other Income | 5.17 | 0.16 | 0.06 | 0.30 | 0.17 | |
| Total Revenue | 77.86 | 73.31 | 63.36 | 56.10 | 43.37 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 18.58 | 20.30 | 16.11 | 15.74 | 12.33 | |
| Purchase Of Stock-In Trade | 2.95 | 2.70 | 1.44 | 0.63 | 0.59 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -0.29 | -3.32 | 0.11 | -0.27 | 1.65 | |
| Employee Benefit Expenses | 35.52 | 20.23 | 15.98 | 12.17 | 13.06 | |
| Finance Costs | 3.92 | 3.83 | 4.44 | 5.89 | 6.05 | |
| Depreciation And Amortisation Expenses | 2.15 | 0.77 | 0.64 | 0.77 | 0.82 | |
| Other Expenses | 28.52 | 28.37 | 25.09 | 19.95 | 15.45 | |
| Total Expenses | 91.34 | 72.88 | 63.82 | 54.87 | 49.95 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -13.48 | 0.43 | -0.46 | 1.23 | -6.58 | |
| Exceptional Items | 0.00 | 0.00 | 2.83 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | -13.48 | 0.43 | 2.37 | 1.23 | -6.58 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 0.28 | 0.06 | 0.40 | 0.07 | 0.00 | |
| Less: MAT Credit Entitlement | 0.00 | 0.06 | 0.40 | 0.07 | 0.00 | |
| Deferred Tax | 0.02 | 0.70 | -0.52 | 0.35 | -1.63 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 0.30 | 0.70 | -0.52 | 0.35 | -1.63 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -13.78 | -0.27 | 2.89 | 0.89 | -4.95 | |
| Profit/Loss From Continuing Operations | -13.78 | -0.27 | 2.89 | 0.89 | -4.95 | |
| Profit/Loss For The Period | -13.78 | -0.27 | 2.89 | 0.89 | -4.95 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | -11.45 | -0.28 | 3.09 | 1.17 | -4.38 | |
| Diluted EPS (Rs.) | -11.45 | -0.28 | 3.09 | 1.17 | -4.38 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
26.11.2025
Kerala Ayur Consolidated September 2025 Net Sales at Rs 34.84 crore, up 9.38% Y-o-Y
24.11.2025
Kerala Ayur Standalone September 2025 Net Sales at Rs 21.29 crore, up 6.27% Y-o-Y
21.07.2025
Kerala Ayur Consolidated June 2025 Net Sales at Rs 28.61 crore, down 0.09% Y-o-Y
21.07.2025
Kerala Ayur Standalone June 2025 Net Sales at Rs 17.57 crore, up 6.08% Y-o-Y
26.11.2025
Kerala Ayur Consolidated September 2025 Net Sales at Rs 34.84 crore, up 9.38% Y-o-Y
24.11.2025
Kerala Ayur Standalone September 2025 Net Sales at Rs 21.29 crore, up 6.27% Y-o-Y
21.07.2025
Kerala Ayur Consolidated June 2025 Net Sales at Rs 28.61 crore, down 0.09% Y-o-Y
21.07.2025
Kerala Ayur Standalone June 2025 Net Sales at Rs 17.57 crore, up 6.08% Y-o-Y
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth